The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

This interview discusses Little Green Pharma’s (ASX:LGP) record-breaking quarterly results for June 2024, highlighting a 12% increase in revenue and significant cash receipts. CEO Paul Long elaborates on the company’s growth drivers, including new product sales in Australia and Europe, and outlines their strategy to maintain market share and expand in emerging European markets.

lgp by the numbers
More From The Market Online
HotCopper Daily Market Trends Graphic

Thursday’s HotCopper trends: Meteoric Resources, Marmota, Manuka Resources and other daily topics

With more than 600k average monthly users on the HotCopper forums, each and every discussion can…
Image of two soldiers looking at a drone

Droneshield up +8% WoW as fresh $720M US contract revives interest

Droneshield (ASX:DRO) has been struggling in particular ever since its founder and directors sold all of their shares out

Prospect Resources unveils latest copper drill hits from Nyungu Central, Zambia

Prospect Resources (ASX:PSC) has unveiled the latest drill hits from its Zambia-based Mumbezhi project’s

Exultant Mining identifies depth potential and extends high-grade zone at Balerion

Exultant Mining has extended a key target at depth at the Balerion prospect, within the company’s…